ASMS 2021 - Bruker's Virtual eXceed Symposia - Expanding the Horizons of Single Cell Research
Bruker: ASMS 2021 - Bruker's Virtual eXceed Symposia - Expanding the Horizons of Single Cell Research
Our events will take place starting on Sunday, October 31st at 8:30 am with our Virtual eXceed Symposia then Monday through Thursday starting at 7:00 am with our Virtual Breakfast Workshops focusing on Proteomics, Pharma/BioPharma, Imaging/SpatialOMx® and Metabolomics. All sessions include live Q&A.
Be sure to also stop by and visit our booth #719 if you are attending ASMS in person, where we will feature our new timsTOF SCP, or request a private demo of our newest software.
We are doing everything we can to ensure that everyone has access to the information we are providing either in person or virtually.
Sunday, October 31, 2021, 08:30 am EDT – 11:45 pm EDT (14:30 - 18:05 CEST)
14:30 - 14:35 (CEST - Prague) Introduction of the Speakers
- Rohan Thakur, Ph.D. (Managing Director and Executive Vice President, Life Sciences Mass Spectrometry, Bruker Daltonics GmbH & Co. KG, Bremen, Germany)
14:35 - 14:45 (CEST - Prague) Welcome and Introduction
- Frank Laukien, Ph.D. (Chairman, President and CEO, Bruker Corporation, Billerica, MA)
14:45 - 15:00 (CEST - Prague) Introduction
- Rohan Thakur, Ph.D. (Managing Director and Executive Vice President, Life Sciences Mass Spectrometry, Bruker Daltonics GmbH & Co. KG, Bremen, Germany)
15:00 - 15:20 (CEST - Prague) Plenary Speaker - Novel scan and analyses modes using PASEF on the Bruker timsTOF
- Prof. Matthias Mann, Ph.D. (Max-Planck Institute of Biochemistry and Clinical Proteomics Group, Martinsried, Germany, Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Denmark)
15:20 - 15:40 (CEST - Prague) Deep Visual Proteomics: Single cell mass spectrometry for molecular cartography of human cancer tissue
- Andreas Mund, Ph.D. (Associate Professor, Clinical Proteomics Group, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark)
15:40 - 16:00 (CEST - Prague) Using Mass Spectrometry to Decipher Diagnose and Drug Dementias
- Judith Steen, Ph.D. (Associate Professor of Neurology, Harvard Medical School, Boston, USA)
16:00 - 16:15 (CEST - Prague) Break
16:15 - 16:35 (CEST - Prague) Structural O-Glycoform Analysis of SARS-CoV-2 Enabled by Top-down Mass Spectrometry and Trapped Ion Mobility
- David Roberts, Chemistry (Ph.D. Student, Ying Ge Lab and Song Jin Lab, University of Wisconsin-Madison, WI, USA)
16:35 - 16:55 (CEST - Prague) Solving riddles in human pharmacology with single cell proteomics
- Ben Orsburn, Ph.D. (Research Faculty, Department of Pharmacology and Molecular Sciences, The Johns Hopkins School of Medicine, Baltimore, MD, USA)
16:55 - 17:15 (CEST - Prague) Highly multiplexed, multiomic and multimodal tissue imaging using novel photocleavable mass-tags
- Mark J Lim, Ph.D. (Executive Vice President and Chief Scientific Officer, AmberGen Inc., Watertown, MA, USA)
17:15 - 17:35 (CEST - Prague) Scaling down with Bruker: metabolite and neuropeptide measurements in individual cells and organelles
- Prof. Jonathan Sweedler, Ph.D. (Director, School of Chemical Sciences, James R. Eiszner Family Chair in Chemistry, Urbana, IL, USA, Editor-in-Chief, Analytical Chemistry, American Chemical Society, Washington D.C., USA)
17:35 - 17:55 (CEST - Prague) Bottom-up and mid-down approaches for the sequence analysis of RNA
- Dan Fabris, Ph.D. (Harold S. Schwenk Sr. Distinguished Chair in Chemistry, Department of Chemistry, University of Connecticut, USA)
17:55 - 18:05 (CEST - Prague) Q&A
- Gary Kruppa, Ph.D. (Vice President, Proteomics, Bruker Daltonics, Billerica, MA)